BioSpace News Archive

Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other pain conditions, recently had the results of a real-world analysis of Nerivio® for acute treatment of migraine in adolescents published in the journal Pediatric Neurology.

AB Science SA announced that Professor Albert Ludolph, MD, PhD, will deliver a presentation on masitinib in amyotrophic lateral sclerosis to an audience of key opinion leaders in the field of ALS healthcare, at the up-coming American Academy of Neurology 2023 Annual Meeting in Boston, USA.

Cold Spring Harbor Laboratory Professor Adrian Krainer is best known for his groundbreaking research on antisense oligonucleotides —molecules that can control protein levels in cells.

Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that Carmine Stengone, CEO of Pipeline, will present a company overview on Wednesday, April 19, 2023, at 3 pm ET at the 22nd Annual Needham Virtual Healthcare Conference.

CTI BioPharma Corp. (Nasdaq: CTIC) today announced that the management team will participate in two upcoming investor conferences in April 2023.

A landmark paper published today in The Lancet Neurology journal by leaders of the Parkinson’s Progression Markers Initiative (PPMI) confirms the most significant breakthrough yet in the search for a Parkinson’s biomarker: a biological test for Parkinson’s disease that demonstrates high diagnostic accuracy, differentiates molecular subtypes and detects disease in individuals before cardinal movement symptoms arise.

Bridge Biotherapeutics (KQ288330) announced it has dosed the first patient in its Phase 2a clinical study to evaluate the efficacy, safety, and tolerability of BBT-877 in patients with idiopathic pulmonary fibrosis (IPF).

Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced its participation at two upcoming investor conferences:

MIM Software Inc. is proud to support the efforts of the Melbourne Theronastic Innovation Centre (MTIC) in Melbourne, Victoria as they launch the use of the Siemens Biograph Vision Quadra PET/CT, one of the few such “all-organ” scanners in the world.

GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced the appointment of Brian Kelly as Senior Vice President of Business Development.